NovaBay Pharmaceuticals Valuation Multiples
Discover NovaBay Pharmaceuticals' revenue and EBITDA valuation multiples and M&A history.
NovaBay Pharmaceuticals Overview
About NovaBay Pharmaceuticals
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
Founded
2000
HQ
Employees
4
Website
Financials (FY)
EV
$40M
Valuation Multiples
Start free trial
NovaBay Pharmaceuticals Stock Performance
NovaBay Pharmaceuticals has current market cap of $37M, and enterprise value of $40M.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $40M | $37M | - | - | - | - | - |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNovaBay Pharmaceuticals Valuation Multiples
NovaBay Pharmaceuticals Financial Valuation Multiples
As of August 14, 2026, NovaBay Pharmaceuticals has market cap of $37M and EV of $40M.
| LTM | Last FY | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified NovaBay Pharmaceuticals Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
NovaBay Pharmaceuticals Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all NovaBay Pharmaceuticals competitors and their valuation data. Start Free Trial | ||||||
NovaBay Pharmaceuticals VC Funding History
Before going public, NovaBay Pharmaceuticals raised $3M in total equity funding, across 1 round.
NovaBay Pharmaceuticals Funding Rounds
Acquisitions by NovaBay Pharmaceuticals
NovaBay Pharmaceuticals has acquired 1 company to date.
Last acquisition by NovaBay Pharmaceuticals was on September 28th 2021. NovaBay Pharmaceuticals acquired DERMAdoctor for $15M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by NovaBay Pharmaceuticals
| Description | DERMAdoctor is a direct-to-consumer skincare brand offering targeted treatments for rosacea, keratosis pilaris, melasma, and anti-aging concerns. Its product lineup includes Physical Chemistry resurfacing gel for rosacea, Ain't Misbehavin' serum for keratosis pilaris, and ZenMed for calming irritated skin. Formulated by dermatologist Dr. Stephen Cominsky, the prestige collection features clinically tested, non-prescription topicals sold online and through retailers like Ulta Beauty. |
| HQ Country |  |
| HQ City | Kansas City, MO |
| Deal Date | 28 Sep 2021 |
| Valuation | $15M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all NovaBay Pharmaceuticals acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout NovaBay Pharmaceuticals
| When was NovaBay Pharmaceuticals founded? | NovaBay Pharmaceuticals was founded in 2000. |
| Where is NovaBay Pharmaceuticals headquartered? | NovaBay Pharmaceuticals is headquartered in United States. |
| How many employees does NovaBay Pharmaceuticals have? | As of today, NovaBay Pharmaceuticals has over 4 employees. |
| Is NovaBay Pharmaceuticals publicly listed? | Yes, NovaBay Pharmaceuticals is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of NovaBay Pharmaceuticals? | NovaBay Pharmaceuticals trades under B9P0 ticker. |
| When did NovaBay Pharmaceuticals go public? | NovaBay Pharmaceuticals went public in 2000. |
| Who are competitors of NovaBay Pharmaceuticals? | NovaBay Pharmaceuticals main competitors include |
| What is the current market cap of NovaBay Pharmaceuticals? | NovaBay Pharmaceuticals' current market cap is $37M. |
| Is NovaBay Pharmaceuticals profitable? | No, NovaBay Pharmaceuticals is not profitable. |
| How many companies NovaBay Pharmaceuticals has acquired to date? | As of August 2026, NovaBay Pharmaceuticals has acquired 1 company. |
| What was the largest acquisition by NovaBay Pharmaceuticals? | $15M acquisition of DERMAdoctor on 28th September 2021 was the largest M&A NovaBay Pharmaceuticals has done to date. |
| What companies NovaBay Pharmaceuticals acquired? | NovaBay Pharmaceuticals acquired DERMAdoctor. |
| In how many companies NovaBay Pharmaceuticals has invested to date? | NovaBay Pharmaceuticals hasn't invested in any companies yet (or none have been disclosed publicly). |
Lists including NovaBay Pharmaceuticals
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.